ANAVEX LIFE SCIENCES CORP. Foreign Currency Transaction Gain (Loss), Unrealized
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$3.06 thousand for the 12-month period ending 2016-09-30, per its 10-K filed 2017-12-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2017-12-11
- ANAVEX LIFE SCIENCES CORP. foreign currency transaction gain (loss), unrealized for the quarter ending 2016-09-30 was -$416.00, a 105.72% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. foreign currency transaction gain (loss), unrealized for the quarter ending 2016-06-30 was $258.00.
- ANAVEX LIFE SCIENCES CORP. foreign currency transaction gain (loss), unrealized for the quarter ending 2016-03-31 was -$5.74K, a 172.59% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. foreign currency transaction gain (loss), unrealized for the quarter ending 2015-12-31 was $2.83K, a 49.58% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. foreign currency transaction gain (loss), unrealized for fiscal 2016 was -$3.06K, a 116.41% decline from fiscal 2015.
- ANAVEX LIFE SCIENCES CORP. foreign currency transaction gain (loss), unrealized for fiscal 2015 was $18.68K, a 0.61% decline from fiscal 2014.
- ANAVEX LIFE SCIENCES CORP. foreign currency transaction gain (loss), unrealized for fiscal 2014 was $18.80K, a 280.76% increase from fiscal 2013.
- ANAVEX LIFE SCIENCES CORP. foreign currency transaction gain (loss), unrealized for fiscal 2013 was $4.94K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month | Foreign Currency Transaction Gain (Loss), Unrealized 110 month | Foreign Currency Transaction Gain (Loss), Unrealized 113 month | Foreign Currency Transaction Gain (Loss), Unrealized 116 month | Foreign Currency Transaction Gain (Loss), Unrealized 119 month | Foreign Currency Transaction Gain (Loss), Unrealized 122 month |
|---|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | -$416.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | -$158.00 derived: sum of 2 quarters · filed 2017-12-11 | -$5.89K derived: sum of 3 quarters · filed 2017-12-11 | -$3.06K 10-K · filed 2017-12-11 | |||||
| 2016-06-30 | $258.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-07 | -$5.48K derived: sum of 2 quarters · filed 2017-08-07 | -$2.65K 10-Q · filed 2017-08-07 | $4.63K derived: sum of 4 quarters · filed 2017-12-11 | |||||
| 2016-03-31 | -$5.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | -$2.91K 10-Q · filed 2017-05-10 | $4.37K derived: sum of 3 quarters · filed 2017-12-11 | $2.27K derived: sum of 4 quarters · filed 2017-12-11 | |||||
| 2015-12-31 | $2.83K 10-Q · filed 2017-02-07 | $10.11K derived: sum of 2 quarters · filed 2017-12-11 | $8.00K derived: sum of 3 quarters · filed 2017-12-11 | $15.90K derived: sum of 4 quarters · filed 2017-12-11 | |||||
| 2015-09-30 | $7.28K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $5.17K derived: sum of 2 quarters · filed 2017-12-11 | $13.07K derived: sum of 3 quarters · filed 2017-12-11 | $18.68K 10-K · filed 2017-12-11 | |||||
| 2015-06-30 | -$2.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-11 | $5.80K derived: sum of 2 quarters · filed 2016-08-11 | $11.40K 10-Q · filed 2016-08-11 | $20.18K derived: sum of 4 quarters · filed 2016-12-14 | |||||
| 2015-03-31 | $7.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-11 | $13.51K 10-Q · filed 2016-05-11 | $22.28K derived: sum of 3 quarters · filed 2016-12-14 | $15.16K derived: sum of 4 quarters · filed 2016-12-14 | |||||
| 2014-12-31 | $5.61K 10-Q · filed 2015-02-17 | $14.38K derived: sum of 2 quarters · filed 2016-12-14 | $7.26K derived: sum of 3 quarters · filed 2016-12-14 | $13.91K derived: sum of 4 quarters · filed 2016-12-14 | |||||
| 2014-09-30 | $8.77K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $1.66K derived: sum of 2 quarters · filed 2016-12-14 | $8.30K derived: sum of 3 quarters · filed 2016-12-14 | $18.80K 10-K · filed 2016-12-14 | |||||
| 2014-06-30 | -$7.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-14 | -$471.00 derived: sum of 2 quarters · filed 2015-08-14 | $10.03K 10-Q · filed 2015-08-14 | $7.68K derived: sum of 4 quarters · filed 2015-08-14 | |||||
| 2014-03-31 | $6.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-14 | $17.14K 10-Q · filed 2015-05-14 | $14.80K derived: sum of 3 quarters · filed 2015-05-14 | $18.49K derived: sum of 4 quarters · filed 2015-05-14 | $22.08K 10-Q/A · filed 2014-05-30 | ||||
| 2013-12-31 | $10.50K 10-Q · filed 2015-02-17 | $8.15K derived: sum of 2 quarters · filed 2015-02-17 | $11.85K derived: sum of 3 quarters · filed 2015-02-17 | $15.44K derived: sum of 4 quarters · filed 2015-02-17 | $15.44K 10-Q · filed 2014-02-14 | ||||
| 2013-09-30 | -$2.35K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | $1.35K derived: sum of 2 quarters · filed 2014-12-29 | $4.94K derived: sum of 3 quarters · filed 2014-12-29 | $4.94K 10-K · filed 2014-12-29 | $4.94K 10-K · filed 2013-12-30 | ||||
| 2013-06-30 | $3.69K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2014-08-13 | $7.28K derived: sum of 2 quarters · filed 2014-08-13 | $7.28K 10-Q · filed 2014-08-13 | $7.28K derived: sum of 4 quarters · filed 2014-08-13 | $7.28K 10-Q · filed 2013-08-14 | ||||
| 2013-03-31 | $3.59K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30 | $3.59K 10-Q/A · filed 2014-05-30 | $3.59K derived: sum of 3 quarters · filed 2014-05-30 | $3.59K derived: sum of 4 quarters · filed 2014-05-30 | $3.59K 10-Q · filed 2013-05-17 | ||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-14 | $0.00 derived: sum of 2 quarters · filed 2014-02-14 | $0.00 derived: sum of 3 quarters · filed 2014-02-14 | ||||||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $0.00 derived: sum of 2 quarters · filed 2013-12-30 | $0.00 10-K · filed 2013-12-30 | ||||||
| 2012-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | |||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |